Filter
1604
Filtered Results: 1604
Text search:
World
Health
Organization.
Regional
Office
for
South-East
Asia
Featured
Recommendations
147
New Publications
423
Language
Document type
No document type
826
Studies & Reports
372
Guidelines
194
Manuals
84
Strategic & Response Plan
63
Training Material
17
Situation Updates
16
Fact sheets
14
Resource Platforms
9
Infographics
5
Brochures
2
Online Courses
2
Countries / Regions
Global
98
South–East Asia Region
67
India
61
Myanmar / Burma
61
Nepal
46
Asia
42
Philippines
31
Bangladesh
29
Western and Central Europe
27
Indonesia
25
Africa
23
Ethiopia
19
Cambodia
18
Kenya
16
Uganda
15
Western Pacific Region
15
Syria
12
Thailand
12
Liberia
11
Pakistan
11
Middle East and North Africa
11
Afghanistan
10
Eastern Europe
10
Tanzania
9
South Africa
9
Ukraine
9
Zambia
8
Sierra Leone
7
Ghana
7
Mozambique
7
Latin America and the Carribbean
7
Nigeria
6
Congo, Democratic Republic of
6
Haiti
6
Somalia
6
Malawi
6
Sri Lanka
6
Yemen
6
Laos
6
Russia
6
Zimbabwe
5
China
5
Rwanda
5
Papua New Guinea
5
East and Southern Africa
5
West and Central Africa
5
South Sudan
4
Sudan
4
Venezuela
4
Moldova
4
Vietnam
4
Guinea
3
Burkina Faso
3
Senegal
3
Iraq
3
Jordan
3
Turkey
3
Central African Republic
3
Eswatini/ Swaziland
3
North Macedonia
3
Eastern Europe and Central Asia
3
Timor Leste/ East Timor
3
Iran
3
Georgia
3
USA
2
Cameroon
2
Lebanon
2
Malaysia
2
Madagascar
2
Mexico
2
Bhutan
2
North Korea
2
Albania
2
Kazakhstan
2
Belarus
2
Bosnia and Herzegovina
2
Guinea-Bissau
1
Morocco
1
Saudi Arabia
1
Egypt
1
Chad
1
Singapore
1
Vanuatu
1
Argentina
1
Peru
1
Brazil
1
Hungary
1
Croatia
1
Colombia
1
Ecuador
1
Greece
1
Angola
1
Lesotho
1
Other region
1
Paraguay
1
Solomon Islands
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Mongolia
1
Canada
1
Tajikistan
1
Qatar
1
Romania
1
Kyrgyzstan
1
North America
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
398
Clinical Guidelines
170
Public Health
113
Women & Child Health
105
Key Resources
88
Capacity Building
27
Pharmacy & Technologies
19
Toolboxes
HIV
164
Mental Health
134
COVID-19
118
Planetary Health
105
TB
74
Rapid Response
67
AMR
62
NTDs
59
Global Health Education
53
Disability
52
Refugee
44
Caregiver
35
Natural Hazards
32
NCDs
28
Conflict
26
Health Financing Toolbox
26
Pharmacy
22
Zika
18
Ebola
16
Specific Hazards
9
Cholera
8
Polio
8
Typhoon
3
Social Ethics
1
Health Financing
1
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria tar...
The 2023 meeting of the WHO Clinical Consortium on Healthy Ageing (CCHA) was the group’s ninth gathering and took place in Geneva 5–7 December 2023. The meeting was structured around seven panels, with a series of technical presentations, plenary discussions and group work, and a final session o...
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence ...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Practical Guidance for collaborative interventions
The global tripartite self-assessment survey of country progress in addressing antimicrobial resistance (AMR) is a component of a broader approach for monitoring and evaluation of the global action plan on AMR. This report analyses the results of th...
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World ... Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Ministry of Health & Family Welfare (MoHFW) identified AMR as one of the top 10 priorities for the ministry’s collaborative work with WHO. The National Health Policy 2017 identifies antimicrobial resistance as a problem and calls for effective action to address it. An international conference on AMR – “Combating Antimicrobial Resistance: A
Public Health Challenge and Priority”, was jointly organized by the Government of India and World Health Organization (WHO) in February 2016, which was attended by more than 350 participants. The Hon’ble Prime Minister, Shri Narendra Modi, and the Hon’ble Union Minister for Health, Shri J.P. Nadda have reiterated government’s commitment to tackle AMR.
A new reportshows that people in some 25 countries are set to face devasting levels of hunger in coming months due to the fallout from the COVID-19 pandemic. While the greatest concentration of need is in Africa, countries in Latin America and the Caribbean, and in the Middle ... and Asia – including middle-income countries - are also being ravaged by crippling levels of food insecurity
The purpose of the PAS III is to guide Pakistan’s overall national response for HIV and AIDS through 2020, through focused interventions with set targets, costs, roles and responsibilities. The successful implementation of PAS III involves multipl...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobi...
Novel coronavirus will disproportionately impact world’s 70 million displaced people
Report recommends stopping asylum seeker deportations, prioritising hygiene and refugee camp decongestion, better communication
Displaced people must be...
A comprehensive compilation is provided of the medicinal plants of the Southeast Asian country of Myanmar (formerly Burma). This contribution, containing 123 families, 367 genera, and 472 species, w...
The present booklet is about gender-responsive substance abuse treatment services for women. It is part of the United Nations Office on Drugs and Crime (UNODC) project to develop tools to support th...
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pande...
